We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REYN:NASDAQReynolds Consumer Products Inc. Analysis

Data as of 2026-04-28 - not real-time

$20.84

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Reynolds Consumer Products is trading at $20.84, which sits below its 20‑day (21.47), 50‑day (22.17) and 200‑day (23.13) simple moving averages, signaling a bearish short‑term momentum. The RSI of 39 points to a near‑oversold condition, while the MACD histogram remains negative, and the stock is hovering just above the identified support level of $20.70 with resistance near $22.52. Volume has been increasing, hinting at growing participation despite the downtrend.
Fundamentally, the company delivers modest revenue growth of 1.4% and healthy operating margins (17.9%). Forward earnings per share are projected at $1.70, yielding a forward PE of 12.3, and the dividend yield stands at an attractive 4.41% with a 64% payout ratio backed by $291 million of free cash flow. Though leverage is elevated (Debt/Equity ≈ 75%), the stock benefits from a low beta (0.5) and moderate 30‑day volatility (20.5%). Analysts’ consensus targets average $25.14, implying ~20% upside, while the market’s extreme greed sentiment (Fear & Greed Index 89.25) adds momentum to the upside narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at $20.70
  • RSI indicating near‑oversold condition
  • Upcoming earnings release on May 6

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus target of $25.14 (~20% upside)
  • Strong dividend yield of 4.41% with sustainable payout
  • Improving forward earnings and low beta

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Stable cash flow generation supporting dividend
  • Defensive consumer‑cyclical positioning
  • Low market sensitivity (beta 0.5) and moderate volatility

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin8.09%
P/E Ratio14.6
ROE13.70%
ROA6.78%
Debt/Equity75.37
P/B Ratio1.9
Op. Cash Flow$477.0M
Free Cash Flow$291.0M

Technical Analysis

TrendBearish
RSI39.2
Support$20.70
Resistance$22.52
MA 20$21.47
MA 50$22.17
MA 200$23.13
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25

Valuation

Fair Value$12.46
Target Price$25.14
Upside/Downside20.65%
GradeFair
TypeBlend
Dividend Yield4.41%

Risk Assessment

Beta0.50
Volatility20.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.